176 related articles for article (PubMed ID: 30297212)
1. Phosphorylated α-synuclein deposits in sural nerve deriving from Schwann cells: A biomarker for Parkinson's disease.
Zhang H; Zhu L; Sun L; Zhi Y; Ding J; Yuan YS; Shen FF; Li X; Ji P; Wang Z; Niu Q; Zhang KZ
Parkinsonism Relat Disord; 2019 Mar; 60():57-63. PubMed ID: 30297212
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
[TBL] [Abstract][Full Text] [Related]
3. Activated Schwann cells and increased inflammatory cytokines IL-1β, IL-6, and TNF-α in patients' sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson's disease.
Zhang H; Wu J; Shen FF; Yuan YS; Li X; Ji P; Zhu L; Sun L; Ding J; Niu Q; Zhang KZ
CNS Neurosci Ther; 2020 May; 26(5):518-526. PubMed ID: 31828965
[TBL] [Abstract][Full Text] [Related]
4. Skin nerve α-synuclein deposits: a biomarker for idiopathic Parkinson disease.
Donadio V; Incensi A; Leta V; Giannoccaro MP; Scaglione C; Martinelli P; Capellari S; Avoni P; Baruzzi A; Liguori R
Neurology; 2014 Apr; 82(15):1362-9. PubMed ID: 24634456
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.
Doppler K; Ebert S; Uçeyler N; Trenkwalder C; Ebentheuer J; Volkmann J; Sommer C
Acta Neuropathol; 2014 Jul; 128(1):99-109. PubMed ID: 24788821
[TBL] [Abstract][Full Text] [Related]
6. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy.
Zange L; Noack C; Hahn K; Stenzel W; Lipp A
Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579
[TBL] [Abstract][Full Text] [Related]
9. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein induces prodromal symptoms of Parkinson's disease via activating TLR2/MyD88/NF-κB pathway in Schwann cells of vagus nerve in a rat model.
Cheng Y; Tong Q; Yuan Y; Song X; Jiang W; Wang Y; Li W; Li Y; Zhang K
J Neuroinflammation; 2023 Feb; 20(1):36. PubMed ID: 36788559
[TBL] [Abstract][Full Text] [Related]
11. The aggregation state of α-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain.
Kuzkina A; Schulmeyer L; Monoranu CM; Volkmann J; Sommer C; Doppler K
Parkinsonism Relat Disord; 2019 Jul; 64():66-72. PubMed ID: 30902527
[TBL] [Abstract][Full Text] [Related]
12. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
[TBL] [Abstract][Full Text] [Related]
13. Detection of alpha-synuclein conformational variants from gastro-intestinal biopsy tissue as a potential biomarker for Parkinson's disease.
Ruffmann C; Bengoa-Vergniory N; Poggiolini I; Ritchie D; Hu MT; Alegre-Abarrategui J; Parkkinen L
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):722-736. PubMed ID: 29676021
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease.
Yan F; Chen Y; Li M; Wang Y; Zhang W; Chen X; Ye Q
Medicine (Baltimore); 2018 Jul; 97(28):e11337. PubMed ID: 29995769
[TBL] [Abstract][Full Text] [Related]
15. Can we use peripheral tissue biopsies to diagnose Parkinson's disease? A review of the literature.
Schneider SA; Boettner M; Alexoudi A; Zorenkov D; Deuschl G; Wedel T
Eur J Neurol; 2016 Feb; 23(2):247-61. PubMed ID: 26100920
[TBL] [Abstract][Full Text] [Related]
16. Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
Shannon KM; Keshavarzian A; Dodiya HB; Jakate S; Kordower JH
Mov Disord; 2012 May; 27(6):716-9. PubMed ID: 22550057
[TBL] [Abstract][Full Text] [Related]
17. Reduced amplitude of the sural nerve sensory action potential in PARK2 patients.
Ohsawa Y; Kurokawa K; Sonoo M; Yamada H; Hemmi S; Iwatsuki K; Hagiwara H; Murakami T; Shirabe T; Shimizu T; Sunada Y
Neurology; 2005 Aug; 65(3):459-62. PubMed ID: 16087916
[TBL] [Abstract][Full Text] [Related]
18. Complications following sural and peroneal nerve biopsies.
Hilton DA; Jacob J; Househam L; Tengah C
J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1271-2. PubMed ID: 17550992
[TBL] [Abstract][Full Text] [Related]
19. Changes of unmyelinated nerve fibers in sural nerve in amyotrophic lateral sclerosis, Parkinson's disease and multiple system atrophy.
Kanda T; Tsukagoshi H; Oda M; Miyamoto K; Tanabe H
Acta Neuropathol; 1996; 91(2):145-54. PubMed ID: 8787147
[TBL] [Abstract][Full Text] [Related]
20. No enhanced (p-) α-synuclein deposition in gastrointestinal tissue of Parkinson's disease patients.
Harapan BN; Frydrychowicz C; Classen J; Wittekind C; Gradistanac T; Rumpf JJ; Mueller W
Parkinsonism Relat Disord; 2020 Nov; 80():82-88. PubMed ID: 32971383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
